US Stock MarketDetailed Quotes
PBYI Puma Biotechnology
- 4.750
- +0.130+2.81%
Close May 7 16:00 ET
- 5.030
- +0.280+5.89%
Pre 08:00 ET
229.13MMarket Cap14.84P/E (TTM)
4.780High4.580Low338.52KVolume4.650Open4.620Pre Close1.60MTurnover1.15%Turnover Ratio10.56P/E (Static)48.24MShares7.73052wk High4.49P/B139.85MFloat Cap2.13052wk Low--Dividend TTM29.44MShs Float279.370Historical High--Div YieldTTM4.33%Amplitude1.600Historical Low4.733Avg Price1Lot Size
Puma Biotechnology Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -17.07%43.77M | 3.34%235.64M | 9.90%72.18M | -1.73%56.12M | -8.32%54.57M | 15.39%52.78M | -9.92%228.03M | 18.64%65.68M | 23.48%57.1M | 11.49%59.52M |
| Operating revenue | -17.07%43.77M | 3.34%235.64M | 9.90%72.18M | -1.73%56.12M | -8.32%54.57M | 15.39%52.78M | -9.92%228.03M | 18.64%65.68M | 23.48%57.1M | 11.49%59.52M |
| Cost of revenue | -18.84%10.73M | 13.77%62.68M | 44.47%24.32M | 6.31%13.28M | -20.52%11.86M | 21.89%13.22M | -13.51%55.09M | 41.54%16.84M | 21.56%12.5M | 24.64%14.92M |
| Gross profit | -16.48%33.04M | 0.01%172.96M | -2.01%47.86M | -3.98%42.83M | -4.24%42.71M | 13.37%39.56M | -8.72%172.94M | 12.37%48.84M | 24.03%44.61M | 7.69%44.6M |
| Operating expense | 0.41%35.34M | -1.78%139.69M | -14.85%33.06M | -4.52%33.62M | 16.22%37.82M | -1.25%35.19M | -24.42%142.22M | 5.99%38.82M | -21.61%35.21M | -43.94%32.54M |
| Selling and administrative expenses | -3.76%21.64M | -1.72%88.43M | -20.86%19.82M | -7.45%22.18M | 18.89%24.46M | 10.21%22.49M | -22.63%89.98M | 11.47%25.04M | -8.14%23.96M | -47.79%20.58M |
| -General and administrative expense | -3.76%21.64M | -1.72%88.43M | -20.86%19.82M | -7.45%22.18M | 18.89%24.46M | 10.21%22.49M | --89.98M | --25.04M | -8.14%23.96M | -47.79%20.58M |
| Research and development costs | 6.93%13.59M | -3.56%50.38M | -6.61%12.87M | 1.72%11.45M | 11.62%13.36M | -16.61%12.71M | -27.31%52.24M | -2.71%13.78M | -40.26%11.25M | -35.80%11.97M |
| Provision for doubtful accounts | --110K | --881K | --367K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Operating profit | -152.67%-2.3M | 8.28%33.27M | 47.74%14.8M | -1.95%9.21M | -59.43%4.89M | 684.34%4.37M | 2,281.40%30.72M | 46.60%10.02M | 204.90%9.39M | 172.49%12.06M |
| Net non-operating interest income expense | 13.98%-2.39M | 0.50%-10.73M | 4.53%-2.64M | 2.97%-2.65M | -1.06%-2.67M | -4.68%-2.78M | 14.77%-10.78M | -2.03%-2.76M | 12.13%-2.73M | 22.37%-2.64M |
| Non-operating interest income | 81.01%972K | 220.42%2.61M | 38.54%719K | 218.98%689K | 915.38%660K | 4,030.77%537K | 408.13%813K | 3,892.31%519K | 1,561.54%216K | -46.28%65K |
| Non-operating interest expense | 1.42%3.36M | 14.99%13.33M | 2.29%3.35M | 13.30%3.34M | 23.06%3.33M | 24.32%3.31M | -9.49%11.59M | 20.64%3.28M | -5.58%2.95M | -23.19%2.7M |
| Other net income (expense) | 316.67%91K | 100.69%134K | 105.10%641K | 92.08%-551K | 1,128.57%86K | -231.25%-42K | -11.69%-19.48M | -4,167.31%-12.57M | 78.65%-6.96M | -99.95%7K |
| Special income (charges) | ---- | 96.79%-625K | --0 | 91.10%-625K | --0 | ---- | -9.69%-19.46M | -6,607.37%-12.36M | 78.50%-7.02M | -100.37%-55K |
| -Less：Restructuring and merger&acquisition | ---- | --0 | --0 | --0 | ---- | ---- | --7M | --0 | --7M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | -29.77%12.46M | 6,607.37%12.36M | -99.94%19K | 100.37%55K |
| -Write off | ---- | --625K | --0 | --625K | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non- operating income (expenses) | 316.67%91K | 2,810.71%759K | 414.22%641K | 15.63%74K | 38.71%86K | -184.00%-42K | -109.59%-28K | -271.43%-204K | -9.86%64K | 3.33%62K |
| Income before tax | -396.83%-4.6M | 4,861.49%22.67M | 341.04%12.8M | 2,150.85%6.01M | -75.47%2.31M | 145.99%1.55M | 101.59%457K | -219.75%-5.31M | 99.34%-293K | 286.03%9.43M |
| Income tax | 49.66%220K | 138.02%1.08M | 82.31%536K | 217.91%213K | 228.07%187K | 297.30%147K | 40.43%455K | 38.68%294K | 81.08%67K | 50.00%57K |
| Net income | -443.68%-4.82M | 1,079,450.00%21.59M | 318.84%12.27M | 1,710.00%5.8M | -77.31%2.13M | 141.17%1.4M | 100.01%2K | -232.72%-5.61M | 99.19%-360K | 283.53%9.37M |
| Net income continuous Operations | -443.68%-4.82M | 1,079,450.00%21.59M | 318.84%12.27M | 1,710.00%5.8M | -77.31%2.13M | 141.17%1.4M | 100.01%2K | -232.72%-5.61M | 99.19%-360K | 283.53%9.37M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -443.68%-4.82M | 1,079,450.00%21.59M | 318.84%12.27M | 1,710.00%5.8M | -77.31%2.13M | 141.17%1.4M | 100.01%2K | -232.72%-5.61M | 99.19%-360K | 283.53%9.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -443.68%-4.82M | 1,079,450.00%21.59M | 318.84%12.27M | 1,710.00%5.8M | -77.31%2.13M | 141.17%1.4M | 100.01%2K | -232.72%-5.61M | 99.19%-360K | 283.53%9.37M |
| Basic earnings per share | -433.33%-0.1 | 1,022,122.22%0.46 | 316.67%0.26 | 1,300.00%0.12 | -76.19%0.05 | 137.50%0.03 | 100.01%0 | -220.00%-0.12 | 99.08%-0.01 | 261.54%0.21 |
| Diluted earnings per share | -433.33%-0.1 | 999,900.00%0.45 | 308.33%0.25 | 1,300.00%0.12 | -76.19%0.05 | 137.50%0.03 | 100.01%0 | -220.00%-0.12 | 99.08%-0.01 | 261.54%0.21 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg